Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.99
+0.48006.39%
Volume:40.84K
Turnover:319.13K
Market Cap:46.81M
PE:-0.70
High:8.01
Open:7.39
Low:7.19
Close:7.51
Loading ...
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Sep 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 03, 2024

Major Issues Report

Form 8-K - Current report
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 11, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 22, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities